Patient Resources
Get Healthy!
162 Results for search "Weight Loss".
Health News Results - 162
Could Ozempic Help Prevent Opioid Overdoses?
- Dennis Thompson HealthDay Reporter
- September 25, 2024
- Full Page
In a finding that suggests Ozempic and Wegovy have powers that extend beyond weight loss, a new study finds the medications might also lower people’s risk of opioid overdose.
...
Novo Nordisk CEO Grilled by Congress Over Price of Ozempic
- Robin Foster HealthDay Reporter
- September 25, 2024
- Full Page
During a tense hearing before a Senate committee on Tuesday, Novo Nordisk CEO Lars Fruergaard Jørgensen faced tough questions over the company's high prices for its block...
Endurance Exercise Can Get Rid of Body Fat, Even Without Weight Loss
- Dennis Thompson HealthDay Reporter
- September 20, 2024
- Full Page
Heavy-duty endurance exercise can cause body fat levels to drop without any accompanying weight loss, a new small-scale study indicates.
A group of eleven middle-aged men who cycled 710 miles in seven days lost only about 1% of their total weight, because they ate and dr...
Cost Has Many Going Around Doctors to Get Weight-Loss Meds
- Dennis Thompson HealthDay Reporter
- September 18, 2024
- Full Page
Wegovy, Zepbound and other cutting-edge weight-loss drugs can be tough to get these days.
They’re in short supply, and often too expensive to afford without insurance cover...
Ozempic Could Curb Progression of Diabetes-Linked Liver Disease
- Ernie Mundell HealthDay Reporter
- September 16, 2024
- Full Page
Fatty liver disease linked to diabetes and obesity can easily progress to liver cirrhosis, but new research suggests that GLP-1 medicines like Ozempic can help stop that.
In a new decades-long study, veterans with diabetes...
Ozempic or Saxenda for Weight Loss: Which Works Best?
- Dennis Thompson HealthDay Reporter
- September 13, 2024
- Full Page
Ozempic and its weight-loss cousin, Wegovy, outperform another longstanding weight-loss drug that targets the same hormone associated with blood sugar and appetite, a new study finds.<...
Ozempic, Mounjaro Help People With Type 1 Diabetes Control Blood Sugar, Lose Weight
- Dennis Thompson HealthDay Reporter
- September 13, 2024
- Full Page
Initially approved to treat type 2 diabetes, Ozempic and Mounjaro also can help people with type 1 diabetes lose weight and control their blood sugar levels, a n...
In Every U.S. State, at Least 1 in 5 People Is Now Obese
- Ernie Mundell HealthDay Reporter
- September 12, 2024
- Full Page
Statistics from 2023 on U.S. obesity rates bring no good news: In every state in the nation, 1 in every 5 people is now obese, the new tally shows.
In 2013, not one state had an adult obesity rate topping 35%, but 10 years later 23 states had achieved that dubious distin...
Weight-Loss Drug Zepbound May Work Better in Women Than Men
- Dennis Thompson HealthDay Reporter
- September 12, 2024
- Full Page
The injectable weight-loss drug Zepbound appears to work better in women than in men, according to a new analysis of the clinical trials that led to its approval.
All doses of tirzepatide consistently reduced weight in...
Ozempic Can Prevent Heart Trouble in Folks With Kidney Issues
- Dennis Thompson HealthDay Reporter
- September 12, 2024
- Full Page
Ozempic and Wegovy can prevent heart problems in overweight and obese people, particularly if they also suffer from kidney disease, a new clinical trial shows.
The drugs’ a...
Weight-Loss Pill Saxenda Helps Kids as Young as 6
- Robin Foster HealthDay Reporter
- September 11, 2024
- Full Page
The weight-loss drug liraglutide helped obese children lower their BMI and reach a healthier weight, researchers report.
The findings, published Tuesday in the New England Journal of Medicine and...
Daily Pill Helps People Lose Weight, Combines GLP-1 With Other Drug
- Dennis Thompson HealthDay Reporter
- September 11, 2024
- Full Page
An experimental weight-loss pill appears to help people quickly shed pounds, a new study says.
People who took the drug amycretin lost up to 13% of their body weight over three months, according to early clinical trial results presented at the European Association for th...
.jpg?w=1920&h=1080&mode=crop&crop=focalpoint)
Obesity Raises Risk of Severe Infection, Especially in People With Diabetes
- Ernie Mundell HealthDay Reporter
- September 9, 2024
- Full Page
Losing weight can help a person with obesity -- especially those with diabetes -- fend off serious infections, new data shows.
It's an important finding, since "up to one in three hospitalizations in people with diabetes are for infections and people with diabetes are tw...
Wegovy, Ozempic May Someday Be Given as Once-Monthly Injection
- Dennis Thompson HealthDay Reporter
- September 9, 2024
- Full Page
A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of the weekly injections they now take, a new study demonstrates.
...
Ozempic, Wegovy Won't Raise User's Suicide Risk, Study Finds
- Dennis Thompson HealthDay Reporter
- September 3, 2024
- Full Page
The booming popularity of the weight-loss drug semaglutide has prompted increasing concerns about potential side effects from taking Ozempic or
Taking Wegovy, Zepbound? One Expert Has Dietary Advice
- Dennis Thompson HealthDay Reporter
- September 3, 2024
- Full Page
Folks taking weight-loss drugs like Wegovy or Zepbound might think they’ve found a shortcut to better health.
But they sti...
Ozempic, Wegovy Have Health Benefits Beyond Weight Loss, Studies Find
- Ernie Mundell HealthDay Reporter
- August 30, 2024
- Full Page
New trials are showing how the blockbuster diabetes and weight-loss meds Ozempic and Wegovy can boost health in even more ways.
These two injected drugs are versions of semaglutide. In multiple new data analyses, the d...
.jpg?w=1920&h=1080&mode=crop&crop=focalpoint)
Why Breast Feeding May Be Even Healthier for Heavier New Moms
- Ernie Mundell HealthDay Reporter
- August 29, 2024
- Full Page
Breastfeeding helps women shed those extra pounds of "pregnancy weight," a new study finds, and the effect is even more pronounced for moms who were overweight before their pregnancy.
Among women who exclusively breastfed their baby during its first year, women who were...
3.6 Million Americans Could Be Covered for Wegovy Under New Medicare Rules
- Dennis Thompson HealthDay Reporter
- August 27, 2024
- Full Page
New Medicare rules could make 3.6 million Americans -- or even more -- eligible for treatment with the pricey weight-loss drug Wegovy, a new study finds.
Under the new rules, the...
.jpeg?w=1920&h=1080&mode=crop&crop=focalpoint)
Getting Fats From Plants Vs. Animals Boosts Your Life Span
- Ernie Mundell HealthDay Reporter
- August 12, 2024
- Full Page
A study of more than 400,000 people tracked for up to 24 years finds that those who got their dietary fat from plants versus animals had significantly lower odds of dying during the study period.
Plant-based fats' benefit included a reduced odds for deaths due to heart d...
Cost Keeps Many Who Need Them From Getting New Weight-Loss Meds
- Dennis Thompson HealthDay Reporter
- August 7, 2024
- Full Page
WEDNESDAY, Aug. 7, 2024 (HealthDay news) -- Medicare and Medicaid patients are less likely to get cutting-edge weight-loss drugs than people with private insurance are, a new study finds.
Legit Ozempic Sales Soar While Counterfeits Put Patients in Danger
- Ernie Mundell HealthDay Reporter
- August 2, 2024
- Full Page
Two new studies show how eager Americans are to obtain either safe, legitimate versions of Ozempic or counterfeit and potentially dangerous forms of the diabetes/weight-loss drug.
One study ...
Study Finds Big Shift in Who's Using GLP-1 Meds Like Ozempic
- Dennis Thompson HealthDay Reporter
- July 23, 2024
- Full Page
The boom in using GLP-1 drugs like Ozempic to treat obesity has resulted in a bust regarding the drugs’ original purpose, which was to treat type 2 diabetes, a new study finds.&...
Four in 10 Cancer Cases, Nearly Half of Cancer Deaths Linked to Lifestyle
- Dennis Thompson HealthDay Reporter
- July 12, 2024
- Full Page
Nearly half of cancer deaths and 4 of 10 cases of cancer are linked to a person's lifestyle, a new study says.
Cigarette smoking remains the biggest cancer risk, contributing to 30% of cancer deaths and 20% of cancer cases, results show.
But excess body weight, dri...
Only 1 in 4 Still Taking Ozempic, Wegovy for Weight Loss Two Years Later
- Robin Foster HealthDay Reporter
- July 11, 2024
- Full Page
Three of four patients stop taking Ozempic or Wegovy two years after being prescribed the blockbuster drugs for weight loss, a new analysis shows.
Conducted by Prime Therapeutics and Magellan Rx Management (MRx), the
Mounjaro Bests Ozempic for Weight Loss
- Dennis Thompson HealthDay Reporter
- July 8, 2024
- Full Page
Mounjaro outperforms Ozempic in helping people lose weight, a new study shows.
People taking tirzepatide (Mounjaro, Zepbound)...
Wegovy, Ozempic Lower Risk of Many Obesity-Related Cancers
- Robin Foster HealthDay Reporter
- July 8, 2024
- Full Page
In yet another finding that touts the health benefits of wildly popular weight-loss medications like Wegovy and Ozempic, scientists report that taking the drugs may help reduce the risk of some cancers.
Another Study Suggests GLP-1 Meds Could Ease Alcoholism
- Dennis Thompson HealthDay Reporter
- July 2, 2024
- Full Page
Cutting-edge weight-loss drugs like Wegovy and Ozempic can help treat alcoholism, a new study says.
People taking semaglutide had 50% to 56% decreased odds for either becoming alcoholic or relapsing into alcoholism, researchers reported recently in the journal
Wegovy Helps Heart Failure Patients Lose Weight, Improve Symptoms
- Dennis Thompson HealthDay Reporter
- June 25, 2024
- Full Page
Weight-loss drugs like Wegovy can improve symptoms in heart failure patients, a new clinical trial shows.
Both men and women showed improved heart function after a year on
Healthy Weight Loss Could Lower Your Odds for Cancer
- Dennis Thompson HealthDay Reporter
- June 25, 2024
- Full Page
Losing weight can protect you against cancers related to obesity, a new study finds.
Obesity has been linked to higher risk of at least 13 types of cancer, researchers said. This is largely due to excess levels of hormones like estrogen and insulin.
But study resul...
GLP-1 Medicine Mounjaro May Be First Drug to Ease Sleep Apnea
- Carole Tanzer Miller HealthDay Reporter
- June 21, 2024
- Full Page
A medication used to manage type 2 diabetes has been found effective in treating sleep apnea.
The worldwide clinical trial demonstrates that tirzepatide significantly lowers breathing interruptions during sleep, a key ...
WHO, Lilly Issue Warnings About Fake Weight-Loss Drugs
- Robin Foster HealthDay Reporter
- June 21, 2024
- Full Page
Both the World Health Organization and Eli Lilly Co. warned Thursday that consumers should avoid fake versions of weight-loss drugs that are circulating in numerous countries.
Looking for Weight Loss? Go Nuts
- Dennis Thompson HealthDay Reporter
- June 20, 2024
- Full Page
Folks dieting to drop pounds should consider eating a fistful of nuts here and there, a new review suggests.
People who ate 1.5 to 3 ounces of almonds, peanuts, pistachios or walnuts daily as part of a calorie-cutting
Taking a GLP-1 Medicine? Here's What Experts Say You Should Eat
- Dennis Thompson HealthDay Reporter
- June 11, 2024
- Full Page
Folks using a weight-loss drugs like Ozempic, Wegovy or Zepbound still have nutritional req...
Wegovy, Ozempic May Help Curb Alcohol Dependence
- Ernie Mundell HealthDay Reporter
- June 4, 2024
- Full Page
Could the blockbuster GLP-1 meds like Wegovy and Ozempic have a role to play in helping people cut down on problem drinking? A new study suggests so.
Researchers at Case Western...
Could New Weight-Loss Drugs Be Changing Women's Taste for Sweets?
- Dennis Thompson HealthDay Reporter
- June 3, 2024
- Full Page
Ozempic and Wegovy appear to improve people's sensitivity to tastes, potentially lowering their desire for sweets, a new study suggests.
The active ingredient in the weight-loss ...
GLP-1 Weight Loss Meds Might Keep Your Pancreas Healthy
- Dennis Thompson HealthDay Reporter
- June 3, 2024
- Full Page
Ozempic and Wegovy might help lower the risk of pancreatitis in patients with obesity and type 2 diabetes, a new study says.
Up to now, doctors have been cautious about prescribing se...
Costs, Side Effects Drive Folks to Quit New Weight-Loss Meds
- Ernie Mundell HealthDay Reporter
- May 23, 2024
- Full Page
Three months after starting one of the new GLP-1 weight-loss drugs, more than a quarter of patients have already quit the medications, and by a year from first use more than a third have stopped, new research shows.
Reasons for quitting Wegovy, Ozempic or similar drugs m...
Use of GLP-1 Meds Have Risen 7-Fold Among Young Americans
- Ernie Mundell HealthDay Reporter
- May 22, 2024
- Full Page
The number of American teens and young adults who've been prescribed one of the new GLP-1 weight-loss drugs soared nearly seven-fold between 2020 and 2023, a new report finds.
That's compared to an overall decline of about 3% in young Americans' use of other types of pre...
'Hungry Gut' Gene Test Shows Who'll Benefit Most From Wegovy
- Robin Foster HealthDay Reporter
- May 21, 2024
- Full Page
You've watched others shed pounds in a matter of weeks after taking one of the new blockbuster weight-loss drugs, so you decide to try one of the medications yourself, only to discover the needle on your bathroom scale barely budges.
Why? New research presented Monday a...
Stomach Paralysis Risk May Rise in People Taking Ozempic and Similar Drugs
- Robin Foster HealthDay Reporter
- May 20, 2024
- Full Page
New, real-world research confirms that the blockbuster weight-loss drugs that millions of Americans have been taking to shed pounds can trigger stomach paralysis in some patients.
"Although these drugs do work and should be used for the right reason, we just want to caut...
More Studies Support Wegovy's Long-Term Weight-Loss Benefits
- Dennis Thompson HealthDay Reporter
- May 14, 2024
- Full Page
Semaglutide -- the active ingredient in the blockbuster weight-loss drugs Ozempic and Wegovy -- can produce long-term weight and heart health benefits, a pair of new studies show.
<...
Wegovy Can Help Heart Failure Patients Reduce Meds: Study
- Ernie Mundell HealthDay Reporter
- May 13, 2024
- Full Page
People with heart failure are often prescribed what are known as loop diuretic medications to help reduce the fluid buildup that's a hallmark of the disease.
Now, research suggests that taking the blockbuster weight loss drug Wegovy (
One in 8 U.S. Adults Have Now Used Blockbuster Meds Like Ozempic
- Dennis Thompson HealthDay Reporter
- May 10, 2024
- Full Page
About 1 in 8 U.S. adults (12%) have tried a weight-loss drug like Wegovy, Ozempic, Zepbound or Mounjaro, a new KFF Health Tracking Poll says.
About 6% are taking one right now, the po...
Stomach-Zapping Procedure Lowers Appetite to Help With Weight Loss
- Dennis Thompson HealthDay Reporter
- May 9, 2024
- Full Page
An experimental procedure could reduce levels of a hunger-triggering hormone by burning part of a person's stomach lining, a new study reports.
In the procedure, doctors snake a tube down the patient's throat with a tiny device that singes the lining of the upper portion...
New Rules Mean 3.6 Million Americans Could Get Wegovy Via Medicare, Costing Billions
- Dennis Thompson HealthDay Reporter
- April 24, 2024
- Full Page
A budget-busting 3.6 million Medicare recipients could now be eligible for coverage of the weight-loss drug Wegovy, a new KFF analysis says.
That's because the U.S. Food and Drug Administration has approved the use of Wegovy (semaglutide) to reduce the risk of
Calories, Not Meal Timing, Key to Weight Loss: Study
- Ernie Mundell HealthDay Reporter
- April 19, 2024
- Full Page
A head-to-head trial of obese, pre-diabetic people who ate the same amount of daily calories -- with one group following a fasting schedule and the other eating freely -- found no difference in weight loss or other health indicators.
So, despite the fact that fasting die...
Weight-loss Drug Zepbound Eases Sleep Apnea in Company Trials
- Robin Foster HealthDay Reporter
- April 17, 2024
- Full Page
Zepbound, one of the wildly popular weight-loss drugs that millions of Americans now take, eased sleep apnea in obese adults in two company trials, drug maker Eli Lilly announced Wednesday.
Mouse Study Shows Microplastics Migrating From Gut to Other Organs
- Dennis Thompson HealthDay Reporter
- April 17, 2024
- Full Page
Microplastics could be migrating from the digestive tract into the kidneys, livers and brains of human beings, a new mouse study suggests.
Lab mice exposed to microplastics in their drinking water wound up with the tiny plastic particles lodged in a number of different o...
Ozempic, Wegovy Won't Boost Thyroid Cancer Risk: Study
- Ernie Mundell HealthDay Reporter
- April 10, 2024
- Full Page
Wegovy, Ozempic and other drugs known as GLP-1 analogues have become wildly popular for controlling diabetes and helping folks lose weight.
There were concerns that longer term use of the drugs might raise users' odds for thyroid cancer, but a Swedish study of more than...